HY-10680-50mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
HY-107397-10mg
|
MedChemexpress LLC
|
Ch55 [CAS 110368-33-7]
|
|
Cancer-programmed cell death
|
|
HY-107397-100mg
|
MedChemexpress LLC
|
Ch55 [CAS 110368-33-7]
|
|
Cancer-programmed cell death
|
|
HY-107397-5mg
|
MedChemexpress LLC
|
Ch55 [CAS 110368-33-7]
|
|
Cancer-programmed cell death
|
|
HY-107397-50mg
|
MedChemexpress LLC
|
Ch55 [CAS 110368-33-7]
|
|
Cancer-programmed cell death
|
|
HY-10862-10mg
|
MedChemexpress LLC
|
FAAH inhibitor 1 [CAS 326866-17-5]
|
|
Cancer-programmed cell death
|
|
HY-10862-100mg
|
MedChemexpress LLC
|
FAAH inhibitor 1 [CAS 326866-17-5]
|
|
Cancer-programmed cell death
|
|
HY-10862-25mg
|
MedChemexpress LLC
|
FAAH inhibitor 1 [CAS 326866-17-5]
|
|
Cancer-programmed cell death
|
|
HY-10862-5mg
|
MedChemexpress LLC
|
FAAH inhibitor 1 [CAS 326866-17-5]
|
|
Cancer-programmed cell death
|
|
HY-10862-50mg
|
MedChemexpress LLC
|
FAAH inhibitor 1 [CAS 326866-17-5]
|
|
Cancer-programmed cell death
|
|
HY-111551-10mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-100mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-5mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-50mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-112136-10mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-112136-100mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-112136-5mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-112136-50mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-113827-5mg
|
MedChemexpress LLC
|
THPN [CAS 100079-26-3]
|
|
COVID-19-immunoregulation
|
|
HY-114483-1mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|
HY-114483-10mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|
HY-114483-100mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|
HY-114483-25mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|
HY-114483-5mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|
HY-114483-50mg
|
MedChemexpress LLC
|
AES-135 [CAS 2361659-61-0]
|
|
Cancer-programmed cell death
|
|